Intuitive Surgical, Inc. $ISRG Shares Sold by C WorldWide Group Holding A S

C WorldWide Group Holding A S cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.0% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 94,311 shares of the medical equipment provider’s stock after selling 5,000 shares during the period. Intuitive Surgical makes up about 0.7% of C WorldWide Group Holding A S’s portfolio, making the stock its 21st largest holding. C WorldWide Group Holding A S’s holdings in Intuitive Surgical were worth $51,250,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Sienna Gestion boosted its holdings in shares of Intuitive Surgical by 10.2% in the 2nd quarter. Sienna Gestion now owns 21,369 shares of the medical equipment provider’s stock valued at $10,602,000 after buying an additional 1,986 shares during the period. Andra AP fonden boosted its holdings in shares of Intuitive Surgical by 37.8% in the 2nd quarter. Andra AP fonden now owns 16,400 shares of the medical equipment provider’s stock valued at $8,912,000 after buying an additional 4,500 shares during the period. Resona Asset Management Co. Ltd. boosted its holdings in shares of Intuitive Surgical by 7.4% in the 2nd quarter. Resona Asset Management Co. Ltd. now owns 223,032 shares of the medical equipment provider’s stock valued at $120,706,000 after buying an additional 15,379 shares during the period. Atlantic Union Bankshares Corp boosted its holdings in shares of Intuitive Surgical by 749.3% in the 2nd quarter. Atlantic Union Bankshares Corp now owns 19,083 shares of the medical equipment provider’s stock valued at $10,370,000 after buying an additional 16,836 shares during the period. Finally, Asahi Life Asset Management CO. LTD. acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at about $712,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 1.8%

ISRG stock opened at $548.55 on Thursday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The company has a market capitalization of $196.64 billion, a price-to-earnings ratio of 72.56, a price-to-earnings-growth ratio of 4.94 and a beta of 1.61. The firm’s 50-day moving average is $468.68 and its two-hundred day moving average is $499.90.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the previous year, the firm earned $1.84 EPS. Intuitive Surgical’s revenue was up 22.9% on a year-over-year basis. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the business’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the sale, the director directly owned 739 shares in the company, valued at approximately $325,669.91. The trade was a 31.19% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Myriam Curet sold 125 shares of the business’s stock in a transaction dated Wednesday, October 29th. The stock was sold at an average price of $543.00, for a total transaction of $67,875.00. The disclosure for this sale is available in the SEC filing. Insiders sold 96,011 shares of company stock worth $50,309,042 in the last three months. Insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on ISRG shares. Evercore ISI boosted their target price on shares of Intuitive Surgical from $450.00 to $540.00 in a research note on Wednesday, October 22nd. Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a research note on Friday, October 31st. Sanford C. Bernstein reissued an “outperform” rating and set a $685.00 target price on shares of Intuitive Surgical in a research note on Tuesday, October 21st. Argus boosted their target price on shares of Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. Finally, Piper Sandler boosted their target price on shares of Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $608.92.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.